Health and Social Care Committee

Drugs policy: medicinal cannabis inquiry

Inquiry status: open

Inquiry launched on Thursday 7 December 2018. The deadline for written submissions was Friday 8 February 2019.

Scope of the inquiry

As the first part of a wider inquiry into the impact of drugs policy on public health, the Committee is seeking evidence on the usage of medicinal cannabis products. The Committee invites written submissions answering the following:

  • What does the current evidence base tell us about the efficacy of medicinal cannabis?
  • What plans are there for research into the medicinal use of cannabis, and what challenges are faced by that research?
  • How suitable are the current procedures for enabling the use of medicinal cannabis in appropriate cases?
  • Do practitioners have the knowledge and products available to them to confidently prescribe medicinal cannabis?
  • Is the current guidance around prescribing CDMPs fit for purpose? 
  • What can we learn from the legalisation of medicinal cannabis and its practical implementation in other countries?
  • Have recent changes in the scheduling and availability of CDMP, and media attention around this, affected public opinion and behaviours in the UK?

 

 

Next meeting(s)

19 March 2019 2:30 pm

Oral Evidence Session

Drugs policy: medicinal cannabis
View details
Witness(es)

Professor Dame Sally Davies, Chief Medical Officer for England
Alette Addison, Head of Pharmacy Development and Regulation, Department of Health and Social Care
Genevieve Edwards, Director of External Affairs, MS Society
Professor Mike Barnes, Interim Chair, Medical Cannabis Clinicians' Society
Peter Carroll, Campaign Director, End Our Pain
Professor Helen Cross, Head of Developmental Neurosciences, UCL GOS Institute of Child Health
Dr Imran Malik, Committee member, Royal College of Psychiatrists
Professor Sanjay Sisodiya, Chair of the ABN Epilepsy Advisory Group, Association of British Neurologists

Location

The Wilson Room, Portcullis House

26 March 2019 2:30 pm

Oral Evidence Session

Drugs policy: medicinal cannabis
View details
Witness(es)

Professor Andrew Goddard, President, Royal College of Physicians
Professor Finbar O'Callaghan, President, British Paediatric Neurology Association
Baroness Blackwood, Parliamentary Under Secretary of State
Professor Chris Whitty, Chief Scientific Advisor, Department for Health and Social Care
Nick Hurd MP, Minister of State for Policing and the Fire Service, Home Office
Dr Keith Ridge, Chief Pharmaceutical Officer, NHS England

Location

Other

News

Receive RSS updates

Share this page